Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FKMMQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,033
Award facts
- Contract value 100% obligated
- $13,033.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,033.17 to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pen (2 mL) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. DUPIXENT (dupilumab) is a biologic medication used to treat moderate-to-severe eczema, asthma, and other allergic inflammatory conditions, representing a specialized pharmaceutical product within the Defense Health System's medical supply requirements.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare systems worldwide. As one of the largest pharmaceutical distributors in the United States, AmerisourceBergen maintains a robust federal contracting portfolio and serves as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare entities through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DB25FKMMQ?
SPE2DB25FKMMQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FKMMQ worth?
The government has obligated $13,033 on SPE2DB25FKMMQ.
Is contract SPE2DB25FKMMQ an order under another contract?
Yes. SPE2DB25FKMMQ is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB25FKMMQ competed?
The extent of competition for SPE2DB25FKMMQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award